Biogen (BIIB) Receivables - Net (2009 - 2026)

Biogen has reported Receivables - Net for 18 years, with the latest figure at $1.9 billion in Q2 2026.

• On a quarterly basis, Receivables - Net rose 16.09% year-over-year to $1.9 billion in Q2 2026; TTM through Jun 2026 was $1.9 billion, a 16.09% increase from a year earlier, with the FY2025 full-year figure at $1.3 billion, down 4.44% from the prior year.
• Receivables - Net was $1.9 billion for Q2 2026 at Biogen, up from $1.4 billion in the prior quarter.
• The five-year high for Receivables - Net was $1.9 billion in Q2 2026, with the low at $4.4 million in Q4 2025.
• Average Receivables - Net over 5 years is $1.5 billion, with a median of $1.6 billion recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: Receivables - Net slumped 99.69% in 2025, then gained 16.09% in 2026.
• Over 5 years, Receivables - Net stood at $1.7 billion in 2022, then declined by 2.4% to $1.7 billion in 2023, then decreased by 15.58% to $1.4 billion in 2024, then plunged by 99.69% to $4.4 million in 2025, then soared by 42754.55% to $1.9 billion in 2026.
• The last three Receivables - Net figures came in at $1.9 billion (Q2 2026), $1.4 billion (Q1 2026), and $4.4 million (Q4 2025), per Business Quant data.